Metraipolis › archive › dc_9dcae5942500

Utilization of the Disease Severity Index (DSI) from the HepQuant DuO Test Enhances Clinical Decision Making in Compensated Advanced Chronic Liver Disease — Europe PMC PMID:41598440

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41598440
DOI
10.3390/jcm15020501
License (as archived)
solo-consultazione
Archived
2026-11-06T23:19:28.002Z
SHA-256 of the archived text
b90369a371a3cd858c97f61a9fe824a5d59ff6ad9edb7d83bc7b9165ba8174fb
Stable URL of this page
https://metraipolis.com/documento/dc_9dcae5942500

How to cite

Utilization of the Disease Severity Index (DSI) from the HepQuant DuO Test Enhances Clinical Decision Making in Compensated Advanced Chronic Liver Disease — Europe PMC PMID:41598440 — Europe PMC (en), https://europepmc.org/article/MED/41598440 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9dcae5942500 (Metraipolis archive dc_9dcae5942500, sha256 b90369a371a3cd858c97f61a9fe824a5d59ff6ad9edb7d83bc7b9165ba8174fb)
BibTeX
@misc{dc9dcae5942500,
  title = {Utilization of the Disease Severity Index (DSI) from the HepQuant DuO Test Enhances Clinical Decision Making in Compensated Advanced Chronic Liver Disease — Europe PMC PMID:41598440},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598440},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9dcae5942500; sha256 b90369a371a3cd858c97f61a9fe824a5d59ff6ad9edb7d83bc7b9165ba8174fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598440. Agents can read the archived copy with the MCP tool read_document.